Why Is CRDO Stock Rising Today? Credo Technology Surges After Q4 Earnings Beat

Credo Technology (CRDO) shares rose 6.12% in premarket trading after the company reported a Q4 FY2026 earnings beat and provided optimistic full-year guidance for FY2027.

The connectivity chip maker delivered across both lines of its earnings report. EPS came in at $1.16 versus the $1.02 consensus, a beat of $0.14. Revenue reached $437 million, edging above the $431.8 million estimate. Year-over-year revenue growth was 157%.

The bigger takeaway was forward guidance. Credo projects full-year FY2027 revenue of $727.2 million, implying strong sequential acceleration from the recent quarter. EPS guidance points to $1.16 in Q1 FY2027, rising to $1.94 by Q4. The Q1 revenue guidance range of $465 million to $475 million also sits above the $462.9 million consensus estimate.

Why Did Investors React?

The reaction reflects more than a single-quarter beat. Credo designs high-speed connectivity semiconductors — including retimers and serializer/deserializer IP — used in data centers and AI clusters. As hyperscalers continue ramping infrastructure for AI workloads, demand for the company's products is accelerating in lockstep.

Wall Street's average price target sits at $268.39, roughly 12% above the current premarket level. Of analysts covering the name, one holds a Strong Buy rating, fifteen rate it a Buy, and three have it on Hold.

A secondary tailwind came from Bloomberg Indices, which announced on August 26 that CRDO would be added to the Bloomberg 500 index effective September 10. Index-tracking funds typically create incremental buying demand around inclusion dates.

What Comes Next?

With pre-market trading running on thinner liquidity, the regular session will determine whether the move broadens or narrows.

The key near-term catalyst is the company's earnings conference call, scheduled for September 1 at 5:00 PM ET. Investors will look to management for color on the sustainability of current growth rates and any updates to segment-level outlook. Guidance that far exceeds consensus sets a high bar — the focus shifts from whether Credo can grow to whether it can grow fast enough.

Bloomberg 500 inclusion on September 10 provides another near-term inflection point. The valuation question remains: at a P/E of roughly 91, the stock is pricing in sustained high growth. Any signs of execution stumbles or competitive pressure from peers could weigh on sentiment.

The average analyst target of $268 and the cluster of catalysts over the coming week — the conference call followed by index inclusion — set the near-term tone. Whether regular-session volume confirms the premarket conviction will be the first test.